XTANT MEDICAL HOLDINGS INC (XTNT) Stock Income Statement
NYSEARCA:XTNT - NYSE Arca - US98420P3082 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 122.30M | 117.27M | 91.30M | 57.97M | 55.26M | |||
| Cost Of Goods | 51.14M | 49.05M | 35.84M | 25.83M | 22.77M | |||
| Gross Profit | 71.16M | 68.22M | 55.47M | 32.14M | 32.49M | |||
| Operating Expenses | 78.70M | 80.29M | 65.63M | 38.89M | 36.34M | |||
| Research and Development | 2.30M | 2.38M | 1.34M | 915.00K | 870.00K | |||
| Selling, General, and Administrative Expenses | 76.40M | 77.91M | 64.29M | 37.98M | 35.47M | |||
| Operating Income | -7.54M | -12.07M | -10.16M | -6.75M | -3.85M | |||
| Interest Income/Expense | -4.30M | -4.16M | -2.52M | -1.66M | -995.00K | |||
| Other Income/Expense | -54.00K | -33.00K | -49.00K | N/A | N/A | |||
| Non Recurring Items | N/A | 0.00 | 11.69M | N/A | N/A | |||
| Income Before Taxes | -11.90M | -16.26M | -1.04M | -8.42M | -4.85M | |||
| Income Tax | 94.00K | 187.00K | -1.70M | 69.00K | 0.00 | |||
| Net Income | -11.99M | -16.45M | 660.00K | -8.48M | -4.85M | |||
| EBITDA | -3.25M | -7.85M | -6.98M | -5.46M | -2.52M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.09 | -0.12 | 0.01 | -0.09 | -0.06 | |||
| Non GAAP EPS | -0.09 | -0.12 | 0.00 | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 58.18% | 58.17% | 60.75% | 55.44% | 58.79% | |||
| Profit Margin | -9.81% | -14.03% | 0.72% | -14.64% | -8.77% | |||
| Operating Profit Margin | -6.17% | -10.30% | -11.13% | -11.65% | -6.97% | |||
All data in USD